PMID: 6980215Apr 1, 1982Paper

Thiolactomycin, a new antibiotic. III. In vitro antibacterial activity

The Journal of Antibiotics
T NotoH Okazaki

Abstract

Thiolactomycin is a new broad-spectrum antibiotic, active in vitro against many species of Gram-positive cocci, Enterobacteriaceae, Haemophilus, acid-fast bacteria and anaerobic bacteria. However, the activity is generally moderate and bacteriostatic in action. This antibiotic eludes cross resistance with any of the known antibacterial drugs such as ampicillin, carbenicillin or cycloserine. The effect on Gram-negative bacilli in vitro is little affected by the inoculum size, the presence of horse serum, the pH of the medium or the type of medium. When thiolactomycin was added to the assay medium, the minimum inhibitory concentration of ampicillin against inducible beta-lactamase producing strains of Staphylococcus aureus and Pseudomonas aeruginosa was reduced. Thiolactomycin inhibited the production of inducible beta-lactamase in several organisms.

Citations

Aug 2, 2002·Expert Opinion on Investigational Drugs·Laurent S Kremer, Gurdyal S Besra
May 31, 2007·The Journal of Biological Chemistry·Agoston JergaCharles O Rock
Jan 9, 2009·Angewandte Chemie·K C NicolaouAnthony A Estrada
Mar 9, 2010·Chemistry, an Asian Journal·Kalanidhi Palanichamy, Krishna P Kaliappan
Mar 5, 2016·International Journal of Medicinal Chemistry·Manik DasKuntal Manna
Jan 27, 2006·Antimicrobial Agents and Chemotherapy·Katherine YoungJun Wang
Nov 2, 2004·The Journal of Biological Chemistry·Srinivas KodaliJun Wang
Aug 31, 2011·Proceedings of the National Academy of Sciences of the United States of America·Joshua B ParsonsCharles O Rock
Jan 15, 2011·Clinical Microbiology Reviews·Lynn L Silver
Sep 15, 2011·The Journal of Antibiotics·Evan Martens, Arnold L Demain
Aug 1, 1987·European Journal of Clinical Microbiology·D M Livermore
Jan 1, 1993·Archives of Microbiology·N Arimura, T Kaneda
Oct 9, 2002·Microbiology·James D DouglasDavid E Minnikin
Apr 26, 2007·Proceedings of the National Academy of Sciences of the United States of America·Jun WangSheo B Singh
Dec 19, 2009·The Journal of Biological Chemistry·Carl A MachuttaPeter J Tonge
Mar 20, 2014·The FEBS Journal·Felipe TrajtenbergGustavo E Schujman
May 2, 2006·The Journal of Biological Chemistry·Yong-Mei ZhangCharles O Rock
Sep 7, 2001·Annual Review of Microbiology·J W Campbell, J E Cronan
Jan 27, 2017·Chemical Communications : Chem Comm·Marie E YurkovichPeter F Leadlay
Jan 7, 2021·Organic & Biomolecular Chemistry·Umesh Kumar BaghaSam P de Visser
May 1, 1999·Antimicrobial Agents and Chemotherapy·B PhetsuksiriP J Brennan
Oct 10, 2001·Progress in Lipid Research·R J HeathC O Rock
Mar 21, 2020·Cell Chemical Biology·Daigo InoyamaJoel S Freundlich
Dec 1, 1996·Antimicrobial Agents and Chemotherapy·R A SlaydenG S Besra
Oct 14, 2003·Bioorganic & Medicinal Chemistry Letters·Suzanne J SeniorGurdyal S Besra
Dec 31, 2003·Bioorganic & Medicinal Chemistry Letters·Suzanne J SeniorGurdyal S Besra
Sep 1, 1993·Microbiological Reviews·K MagnusonJ E Cronan
Feb 13, 2007·Bioorganic & Medicinal Chemistry·Yves L Janin
May 18, 2016·Journal of Medicinal Chemistry·Gopal R BommineniPeter J Tonge
May 18, 2007·Bioorganic & Medicinal Chemistry Letters·Kohei Ohata, Shiro Terashima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.